The carcinoid syndrome (CS) becomes manifest when vasoactive substances from the tumors, such as serotonin, tachykinins, bradykinins, kallikrein, histamine, vasoactive intestinal peptide (VIP), prostaglandins, and substance P enter the systemic circulation escaping hepatic degradation. The gene discussed is VIP; the disease is Cowden syndrome 1.